Rifamycin in Minimal Hepatic Encephalopathy

NCT04082780 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

FED

Sponsor class

Conditions

Hepatic Encephalopathy
Cirrhosis, Liver

Interventions

DRUG: Rifamycin SV MMX
OTHER: Placebo

Sponsor

Hunter Holmes Mcguire Veteran Affairs Medical Center